Holen Sie sich die Stockscreener-App
81.71
3.21%
-2.71
Handel nachbörslich:
83.35
1.64
+2.01%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$84.42
Offen:
$83.715
24-Stunden-Volumen:
2.87M
Relative Volume:
0.74
Marktkapitalisierung:
$39.72B
Einnahmen:
$6.13B
Nettoeinkommen (Verlust:
$272.21M
KGV:
148.00
EPS:
0.5521
Netto-Cashflow:
$1.38B
1W Leistung:
-7.34%
1M Leistung:
-7.17%
6M Leistung:
+1.64%
1J Leistung:
+27.12%
1-Tages-Spanne:
$81.56
$84.30
1-Wochen-Bereich:
$81.56
$89.68
52-Wochen-Spanne:
$61.76
$91.06
Ventas Inc Stock (VTR) Company Profile
Firmenname
Ventas Inc
Sektor
Telefon
(312) 660-3800
Adresse
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, OHI, DOC, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
81.71 | 41.04B | 6.13B | 272.21M | 1.38B | 0.5521 |
WELL
Welltower Inc
|
197.36 | 144.95B | 11.75B | 1.46B | 2.19B | -0.6014 |
OHI
Omega Healthcare Investors Inc
|
45.38 | 13.93B | 1.24B | 655.98M | 857.80M | 2.063 |
DOC
Healthpeak Properties Inc
|
19.00 | 13.20B | 2.87B | 250.10M | 1.13B | 0.3188 |
AHR
American Healthcare Reit Inc
|
47.23 | 10.11B | 2.27B | 70.82M | 165.88M | 0.4079 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | Goldman | Buy |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-09-19 | Eingeleitet | UBS | Neutral |
| 2025-06-23 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-03-07 | Hochstufung | Argus | Hold → Buy |
| 2025-01-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-03-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-02-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2024-01-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-07 | Hochstufung | Wedbush | Neutral → Outperform |
| 2023-10-11 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-10-03 | Eingeleitet | Wedbush | Neutral |
| 2023-09-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-08-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-20 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-01 | Bestätigt | Credit Suisse | Outperform |
| 2022-11-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-23 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | CapitalOne | Overweight |
| 2022-05-18 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-03-11 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-03-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-12-14 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-11-22 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2021-10-04 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-09-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-09-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-08-26 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-14 | Fortgesetzt | Mizuho | Neutral |
| 2021-06-15 | Eingeleitet | Wolfe Research | Outperform |
| 2021-06-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-13 | Hochstufung | KeyBanc Capital Markets | Underweight → Overweight |
| 2021-05-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-01-08 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-06 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-11-30 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-11-10 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-09-08 | Herabstufung | Argus | Buy → Hold |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-08-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-08-14 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2020-08-14 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-06-15 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-03-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-03-10 | Herabstufung | Jefferies | Buy → Underperform |
| 2020-02-28 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2020-01-22 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2020-01-17 | Hochstufung | Jefferies | Hold → Buy |
| 2019-12-20 | Fortgesetzt | Mizuho | Neutral |
| 2019-12-10 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-11-19 | Hochstufung | Argus | Hold → Buy |
| 2019-10-30 | Herabstufung | Stifel | Buy → Hold |
| 2019-10-28 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2019-10-28 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Ventas Inc Aktie (VTR) Neueste Nachrichten
Ventas Inc (VTR) Shares Fall 3.2% -- GF Value Says Still Overvalued - GuruFocus
VTR: Senior housing growth accelerates, with raised 2026 guidance and strong financial performance - TradingView
(VTR) Ventas Reaffirms 2026 Normalized FFO Per Share Outlook of $3.82$3.89 - marketscreener.com
Ventas Inc. stock (US92276F1003): shares steady after latest market update - AD HOC NEWS
Ventas Issues Business Update and Will Participate in Investor Meetings at Nareit’s REITweek 2026 Investor Conference - Business Wire
Why Is Healthcare Real Estate Demand Keeping Ventas in Focus? - Kalkine Media
Ventas (NYSE:VTR) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
Ventas Inc stock (US9182041080): shares steady as U.S. healthcare REIT tracks sector moves - AD HOC NEWS
Ventas, Inc. $VTR Shares Sold by Lasalle Investment Management Securities LLC - MarketBeat
Wells Fargo Adjusts Price Target on Ventas to $96 From $93, Maintains Overweight Rating - marketscreener.com
Thames Capital Management LLC Makes New $4.78 Million Investment in Ventas, Inc. $VTR - MarketBeat
National Pension Service Purchases 91,389 Shares of Ventas, Inc. $VTR - MarketBeat
Geode Capital Management LLC Has $1 Billion Position in Ventas, Inc. $VTR - MarketBeat
What's in the offing for Ventas stock this earnings season? - MSN
Welltower And Ventas Share The Same Demand Story, But Their Dividend Structures Do NotVentas (NYSE:VTR - Benzinga
Top Ventas (VTR) Competitors 2026 - MarketBeat
Ventas is buying The Bristal Assisted Living facility in Westbury, plans $1.2M in upgrades - Newsday
Ventas Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Ford, Ventas, QXO And More On CNBC's 'Final Trades' - Benzinga
U.S. REIT At-The-Market Activity Dips In Q1 2026 - Seeking Alpha
Final Trades: Ventas, Ford, QXO and the COWZ - CNBC
Ventas Inc. stock (US92276F1003): Healthcare REIT focuses on senior housing recovery after latest re - AD HOC NEWS
Why Ventas (VTR) is a Top Dividend Stock for Your Portfolio - Yahoo Finance
Price-Driven Insight from (VTR) for Rule-Based Strategy - Stock Traders Daily
Analysts Offer Insights on Real Estate Companies: Federal Realty (FRT) and Ventas (VTR) - The Globe and Mail
BofA Securities Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $110 - Moomoo
BofA Adjusts Price Target on Ventas to $110 From $102 - marketscreener.com
Mizuho Securities Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $98 - Moomoo
PGGM Investments Takes Position in Ventas, Inc. $VTR - MarketBeat
Legal & General Group Plc Grows Stock Holdings in Ventas, Inc. $VTR - MarketBeat
Swedbank AB Purchases 34,329 Shares of Ventas, Inc. $VTR - MarketBeat
Retirement Homes Sell for $41M (NWA Real Deals) - Arkansas Business
Jefferies Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $100 - 富途牛牛
Diamond Hill Capital Management Inc. Sells 12,199 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas Analyst Ratings and Price Targets | NYSE:VTR - Benzinga
Mizuho raises Ventas stock price target to $98 on higher estimates By Investing.com - Investing.com South Africa
Mizuho raises Ventas stock price target to $98 on higher estimates - Investing.com
Baird Adjusts Price Target on Ventas to $98 From $97, Maintains Outperform Rating - marketscreener.com
Mizuho Adjusts Price Target on Ventas to $98 From $94, Maintains Outperform Rating - marketscreener.com
Ventas Inc. stock (US92276F1003): ATM expansion and SHOP growth keep healthcare REIT in focus - AD HOC NEWS
Ventas Is Maintained at Sector Perform by Scotiabank - Moomoo
Ventas stock (US9182041080): Scotiabank raises target to $95 - AD HOC NEWS
Scotiabank Maintains Ventas Inc(VTR.US) With Hold Rating, Raises Target Price to $95 - 富途牛牛
Scotiabank Adjusts Price Target on Ventas to $95 From $93, Maintains Sector Perform Rating - marketscreener.com
Ventas, Inc. $VTR Shares Sold by Handelsbanken Fonder AB - MarketBeat
Ventas Inc. Earnings Call Signals Strong SHOP Surge - TipRanks
Aew Capital Management L P Sells 87,710 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas stock (US92276F1003): ATM expansion puts capital flexibility in focus - AD HOC NEWS
Ventas’s SWOT analysis: healthcare REIT stock faces demographic tailwinds - Investing.com India
Ventas Expands ATM Program to Bolster Capital Flexibility - TipRanks
Ventas stock (US92276F1003): Healthcare REIT outlines growth strategy after recent quarterly results - AD HOC NEWS
Finanzdaten der Ventas Inc-Aktie (VTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):